MedTrace Logo

Short-term Topical Application to Prevent Atopic Dermatitis

NCT03871998 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 321

Last updated 2022-06-22

No results posted yet for this study

Summary

This is a randomised, open-label, controlled study designed to investigate the effect of short-term neonatal skin barrier protection using a commercially available moisturiser on the prevention of atopic dermatitis and food allergy in high risk children.

Conditions

Interventions

OTHER

Skin barrier protection in the first 2 months of life

Skin barrier protection in the first 2 months of life using a commercially available moisturiser from birth 2 months. Twice daily, whole-body application.

Sponsors & Collaborators

  • University College Cork

    lead OTHER

Principal Investigators

  • Jonathan O'B Hourihane, MD · Royal College of Surgeons in Ireland

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
0 Days
Max Age
5 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-04-16
Primary Completion
2021-11-30
Completion
2021-11-30

Countries

  • Ireland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03871998 on ClinicalTrials.gov